Cramer's Morning Take: Eli Lilly & Salesforce 2/27/24
Jim Cramer discusses the Club’s recommendation to buy Eli Lilly. Cramer also says there’s a ‘red flag’ for Salesforce ahead of earnings. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake